Insider · CIK 0001771961

Azoy Alexander

Reports to the SEC for 3 companies · HAYWARD, CA

sec.gov

Transactions

Companies

Filings

CIK

0001771961

Forms 4 and 5

Insider transactions

43 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-21	RCUSArcus Biosciences, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	−2,827 sh	—	—	3,073
2026-08-21	RCUSArcus Biosciences, Inc.S Sale	Chief Accounting Officer	SSale	−2,827 sh	$30.00	−$84.8K	39,581
2026-08-21	RCUSArcus Biosciences, Inc.M Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	+2,827 sh	$15.44	+$43.6K	42,408
2026-06-01	RCUSArcus Biosciences, Inc.S Sale	Chief Accounting Officer	SSale	−2,562 sh	$25.77	−$66K	39,581
2026-01-23	RCUSArcus Biosciences, Inc.A Award	Chief Accounting Officer	AAward	+21.1K sh	—	—	39,581
2026-01-23	RCUSArcus Biosciences, Inc. · Stock Option (right to buy)A Award	Chief Accounting Officer	AAward	+14.1K sh	—	—	14,050
2025-12-18	RCUSArcus Biosciences, Inc.S Sale	Chief Accounting Officer	SSale	−4,343 sh	$22.25	−$96.6K	18,531
2025-12-17	RCUSArcus Biosciences, Inc.S Sale	Chief Accounting Officer	SSale	−2,113 sh	$22.16	−$46.8K	22,874
2025-12-16	RCUSArcus Biosciences, Inc.S Sale	Chief Accounting Officer	SSale	−2,376 sh	$21.88	−$52K	24,987
2025-11-26	RCUSArcus Biosciences, Inc.S Sale	Chief Accounting Officer	SSale	−1,900 sh	$26.00	−$49.4K	27,363
2025-11-26	RCUSArcus Biosciences, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	−1,900 sh	—	—	9,500
2025-11-26	RCUSArcus Biosciences, Inc.M Exercise/Conversion	Chief Accounting Officer	MExercise/Conversion	+1,900 sh	$13.33	+$25.3K	29,263
2025-09-29	RCUSArcus Biosciences, Inc.S Sale	Chief Accounting Officer	SSale	−2,831 sh	$13.00	−$36.8K	27,363
2025-09-05	RCUSArcus Biosciences, Inc.S Sale	Chief Accounting Officer	SSale	−1,579 sh	$11.88	−$18.8K	30,194
2025-01-23	RCUSArcus Biosciences, Inc.A Award	Chief Accounting Officer	AAward	+17.1K sh	—	—	30,194
2025-01-23	RCUSArcus Biosciences, Inc. · Stock Option (right to buy)A Award	Chief Accounting Officer	AAward	+11.4K sh	—	—	11,400
2024-12-19	RCUSArcus Biosciences, Inc.D Disposition to Issuer	Chief Accounting Officer	DDisposition to Issuer	−3,007 sh	$15.17	−$45.6K	13,094
2024-12-15	RCUSArcus Biosciences, Inc.F Tax Payment	Chief Accounting Officer	FTax Payment	−2,969 sh	$16.08	−$47.7K	16,101
2024-12-02	RCUSArcus Biosciences, Inc.S Sale	Chief Accounting Officer	SSale	−201 sh	$15.32	−$3,079.32	19,070
2024-08-13	RCUSArcus Biosciences, Inc.S Sale	Chief Accounting Officer	SSale	−1,357 sh	$14.97	−$20.3K	19,070
2024-01-23	RCUSArcus Biosciences, Inc. · Stock Option (right to buy)A Award	Chief Accounting Officer	AAward	+5,900 sh	—	—	5,900
2024-01-23	RCUSArcus Biosciences, Inc.A Award	Chief Accounting Officer	AAward	+8,850 sh	—	—	19,070
2023-12-20	RCUSArcus Biosciences, Inc.D Disposition to Issuer	Chief Accounting Officer	DDisposition to Issuer	−68 sh	$18.21	−$1,238.28	10,220
2023-12-19	RCUSArcus Biosciences, Inc.D Disposition to Issuer	Chief Accounting Officer	DDisposition to Issuer	−661 sh	$18.09	−$12K	10,288
2023-12-18	RCUSArcus Biosciences, Inc.D Disposition to Issuer	Chief Accounting Officer	DDisposition to Issuer	−647 sh	$17.74	−$11.5K	10,949
2023-12-01	RCUSArcus Biosciences, Inc.S Sale	Chief Accounting Officer	SSale	−282 sh	$14.95	−$4,215.9	11,596
2023-07-03	RCUSArcus Biosciences, Inc.S Sale	Chief Accounting Officer	SSale	−1,018 sh	$20.41	−$20.8K	11,596
2020-09-13	Unity Biotechnology, Inc.A Award	See Remarks	AAward	+135K sh	—	—	135,000
2019-10-02	Sienna Biopharmaceuticals, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−2,396 sh	$0.23	−$551.08	103,552
2019-08-06	Sienna Biopharmaceuticals, Inc.Stock Options (Right to buy)A Award	Chief Financial Officer	AAward	+25K sh	—	—	25,000
2019-08-06	Sienna Biopharmaceuticals, Inc.Stock Options (Right to buy)A Award	Chief Financial Officer	AAward	+5,600 sh	—	—	5,600
2019-08-06	Sienna Biopharmaceuticals, Inc.Stock Options (Right to buy)A Award	Chief Financial Officer	AAward	+8,750 sh	—	—	8,750
2019-08-06	Sienna Biopharmaceuticals, Inc.Stock Options (Right to buy)A Award	Chief Financial Officer	AAward	+8,750 sh	—	—	8,750
2019-08-06	Sienna Biopharmaceuticals, Inc.Stock Options (Right to buy)A Award	Chief Financial Officer	AAward	+20K sh	—	—	20,000
2019-08-06	Sienna Biopharmaceuticals, Inc.Stock Options (Right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−8,750 sh	—	—	0
2019-08-06	Sienna Biopharmaceuticals, Inc.A Award	Chief Financial Officer	AAward	+70K sh	—	—	105,948
2019-08-06	Sienna Biopharmaceuticals, Inc.Stock Options (Right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−25K sh	—	—	0
2019-08-06	Sienna Biopharmaceuticals, Inc.Stock Options (Right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−5,600 sh	—	—	0
2019-08-06	Sienna Biopharmaceuticals, Inc.Stock Options (Right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−20K sh	—	—	0
2019-08-06	Sienna Biopharmaceuticals, Inc.Stock Options (Right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−8,750 sh	—	—	0
2019-07-02	Sienna Biopharmaceuticals, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−1,552 sh	$0.76	−$1,179.52	35,948
2019-04-01	Sienna Biopharmaceuticals, Inc.Stock Options (Right to buy)A Award	Chief Financial Officer	AAward	+20K sh	—	—	20,000
2019-04-01	Sienna Biopharmaceuticals, Inc.A Award	Chief Financial Officer	AAward	+20K sh	—	—	37,500

Recent filings

Accepted (ET)
Aug 244
Azoy Alexander0001771961-26-000006
SEC(opens sec.gov)
Jun 14
Azoy Alexander0001771961-26-000004
SEC(opens sec.gov)
Jan 264
Azoy Alexander0001771961-26-000002
SEC(opens sec.gov)
Dec 184
Azoy Alexander0001771961-25-000014
SEC(opens sec.gov)
Dec 14
Azoy Alexander0001771961-25-000009
SEC(opens sec.gov)
Sep 304
Azoy Alexander0001771961-25-000006
SEC(opens sec.gov)
Sep 54
Azoy Alexander0001771961-25-000003
SEC(opens sec.gov)
Jan 274
Azoy Alexander0001724521-25-000016
SEC(opens sec.gov)
Dec 204
Azoy Alexander0001724521-24-000187
SEC(opens sec.gov)
Dec 174
Azoy Alexander0001724521-24-000179
SEC(opens sec.gov)
Dec 44
Azoy Alexander0001724521-24-000162
SEC(opens sec.gov)
Aug 154
Azoy Alexander0001724521-24-000141
SEC(opens sec.gov)

Companies

Address

C/O ARCUS BIOSCIENCES, INC. 3928 POINT EDEN WAY

HAYWARD, CA, 94545